On May 16, Ferring Pharmaceuticals Korea announced that the company appointed Min-Jung Kim as its new general manager, effective as of May 1.

The new GM joined the company in 2021 as Chief Financial Officer (CFO). Kim has over 20 years of experience in finance, business development, SCM, IT, and human resources at global pharmaceutical and medical device companies, including Novartis Korea and Pentax Medical Korea.

In 2022, Kim served as the Chief Financial Officer for the Northern Asia region, where she improved Ferring's financial circumstances and drove business growth based on her financial expertise and strategic planning capabilities She also has verified her management capabilitie